Please ensure Javascript is enabled for purposes of website accessibility

Live: Coronavirus Market Crash Coverage

The Motley Fool’s live guide on what investors should do during the stock market crash and the COVID-19 pandemic.

We’ve created this page for all investors seeking advice on what they should be doing in this turbulent period. Our most important content can be found in the Editors' Picks, section.

We do believe this will all end up behind us, because we view investing as a long-term endeavor. Borrowing from Warren Buffett: "We have no idea -- and never have had -- whether the market is going to go up, down, or sideways in the near- or intermediate-term future." However, we firmly believe investors will be rewarded over the long term.

We suggest bookmarking this page as we will update our Editors' Picks periodically -- the Recent Articles section is a live feed of our latest thinking. Finally, we understand that many people are seeking epidemiological information on COVID-19. For that we strictly suggest visiting the information pages set up by the CDC and WHO.

For members of The Motley Fool's investing services, you can access all our Coronavirus market coverage at after logging in.

Recent articles

Vaccine being given to young man

Why Novavax Stock Is Jumping Again Today

Investors like that the vaccine maker will soon begin an additional clinical trial targeting the delta variant.

COVID vaccine and Taiwan flag

Why Dynavax Stock Is Skyrocketing 45.8% This Week

One of the company's partners launched its COVID-19 vaccine in Taiwan.

Bull tearing through newspaper stock info

3 Top COVID Vaccine Stocks That Wall Street Is Bullish About

Hint: Pfizer, BioNTech, and Moderna didn't make the list.

Scales with 2 money bags

3 Reasons BioNTech Isn't Nearly as Big as Moderna

Bigger isn't always better.

COVID vaccine vials in a row

Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now

The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet.

Binoculars- man seeing charts trending down

Why 1 Analyst Predicts Moderna Stock Will Plunge Nearly 70%

The vaccine stock could be priced for even more than perfection.

Older woman about to get vaccine

Why Pfizer and Moderna Won't Make As Much Extra Money From U.S. Booster Doses As You Might Think

There are two simple reasons.

Delayed speech bubble

Is Novavax Stock Still a Buy With Its Management's Credibility Crumbling?

The company's executives have repeatedly overpromised and underdelivered.

Worried woman with laptop

Is a Meltdown on the Way for Moderna Stock?

There are certainly reasons to think the biotech stock is overpriced right now.

Vaccine being given to young woman by female doctor

3 Big Hints That COVID Vaccine Booster Doses Are on the Way

The writing could already be on the wall.

Delta variant sign with dark clouds

Worries About the Delta Variant Could Be Overdone Based on Clues From These Healthcare Giants

What healthcare executives are saying so far about the impact of the coronavirus variant on their businesses is reassuring.

Vaccine bottles forming a dollar sign

200 Million More Reasons to Buy Pfizer Stock

The giant drugmaker just landed another big supply deal.

Doctor with vaccine syringe and question mark

Is It Too Late to Buy Novavax Stock?

The answer is in the first two letters of the vaccine maker's name.

Dollar signs above a businessman's hands

How in the World Is Moderna Valued at More Than Half of Pfizer's Market Cap?

There are four possible answers.

Vaccine being given to young man

Are Booster Doses of Pfizer's and Moderna's COVID Vaccines on the Way?

It's only a maybe for now.

Stock market quotes

Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?

There's no guarantee that the biotech's share price will continue climbing.

Arrow pointing down, dollar sign, green arrow pointing up

This Stock Should Soar If the Stock Market Crashes This Summer

It's the most likely winner benefiting from the most likely reason that an imminent crash might occur.

Dividends bag under umbrella

3 Things Every Investor Should Know About Pfizer's Dividend

Hint: There's a lot to like.


2 Under-the-Radar Stocks to Buy Now

The stocks have huge upside potential that investors are overlooking.

Coronavirus with stock chart trending down

Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week

The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.